Oestrogen and nerve growth factor – neuroprotection and repair in Alzheimer’s disease

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Expert Opinion on Investigational Drugs

• Publication date

  2000-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1517/13543784.9.4.685PMID 11060702
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selective Estrogen Receptor Modulators

  2012cited by this paper
• Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome.

  2000cited by this paper
• Reactive oxygen species: the unavoidable environmental insult?

  1999cited by this paper
• Use of hormone replacement therapy among cardiac patients at a Canadian academic centre.

  1999cited by this paper
• Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype.

  1999cited by this paper
• New order from neurological disorders

  1999cited by this paper
• Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

  1999cited by this paper
• Translating cell biology into therapeutic advances in Alzheimer's disease

  1999influential reference
• Recent Developments in the Drug Treatment of Alzheimer’s Disease

  1999cited by this paper
• Are presenilins intramembrane-cleaving proteases? Implications for the molecular mechanism of Alzheimer's disease.

  1999cited by this paper
• In mice tonic estrogen replacement therapy improves non-spatial and spatial memory in a water maze task.

  1999cited by this paper
• Hormone replacement therapy and risk of breast cancer.

  1999cited by this paper
• Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy.

  1999cited by this paper
• Alzheimer β protein mediated oxidative damage of mitochondrial DNA: Prevention by melatonin

  1999cited by this paper
• Estrogen improves working but not reference memory and prevents amnestic effects of scopolamine of a radial-arm maze.

  1999cited by this paper
• A Non-invasive System for Delivering Neural Growth Factors across the Blood-Brain Barrier: A Review

  1998cited by this paper
• Attitudes of Obstetricians and Gynecologists toward Hormone Replacement Therapy

  1998cited by this paper
• Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT)

  1998cited by this paper
• The secretion of amyloid β-peptides is inhibited in the tacrine-treated human neuroblastoma cells

  1998cited by this paper
• Etiology and pathogenesis of Alzheimer's disease.

  1998cited by this paper
• Mitogen‐Activated Protein Kinase‐Dependent and Protein Kinase C‐Dependent Pathways Link the m1 Muscarinic Receptor to β‐Amyloid Precursor Protein Secretion

  1998cited by this paper
• Processing of the Alzheimer's disease amyloid precursor protein in Pichia pastoris: immunodetection of alpha-, beta-, and gamma-secretase products.

  1998cited by this paper
• Neurotrophin binding to the p75 neurotrophin receptor is necessary but not sufficient to mediate NGF-effects on APP secretion in PC-12 cells.

  1998cited by this paper
• Neurotrophic activities and therapeutic experience with a brain derived peptide preparation.

  1998cited by this paper
• Mitogen-activated protein kinase-dependent and protein kinase C-dependent pathways link the m1 muscarinic receptor to beta-amyloid precursor protein secretion.

  1998cited by this paper
• Estrogen attenuates over-expression of beta-amyloid precursor protein messager RNA in an animal model of focal ischemia.

  1998cited by this paper
• Alzheimer's disease

  1998cited by this paper
• Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.

  1998cited by this paper
• The secretion of amyloid beta-peptides is inhibited in the tacrine-treated human neuroblastoma cells.

  1998cited by this paper
• Cellular and molecular basis of estrogen's neuroprotection. Potential relevance for Alzheimer's disease.

  1998cited by this paper
• Estrogens influence growth, maturation, and amyloid beta-peptide production in neuroblastoma cells and in a beta-APP transfected kidney 293 cell line.

  1997cited by this paper
• Hormone replacement therapy and risk for breast cancer.

  1997cited by this paper
• Ovarian steroids and the brain

  1997cited by this paper
• Neurotrophins and their receptors in nerve injury and repair.

  1997cited by this paper
• Amyloid precursor protein potentiates the neurotrophic activity of NGF.

  1997cited by this paper
• Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease.

  1997cited by this paper
• Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease.

  1997cited by this paper
• Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease

  1996cited by this paper
• The Estrogen/Neurotrophin Connection during Neural Development: Is Co-Localization of Estrogen Receptors with the Neurotrophins and Their Receptors Biologically Relevant?

  1996cited by this paper
• Systemic Administration of a Nerve Growth Factor Conjugate Reverses Age-Related Cognitive Dysfunction and Prevents Cholinergic Neuron Atrophy

  1996cited by this paper
• The estrogen/neurotrophin connection during neural development: is co-localization of estrogen receptors with the neurotrophins and their receptors biologically relevant?

  1996cited by this paper
• Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease.

  1996cited by this paper
• Is There a Role for Estrogen Replacement Therapy in the Prevention and Treatment of Dementia?

  1996cited by this paper
• Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

  1996cited by this paper
• Atrophy of cholinergic basal forebrain neurons following excitotoxic cortical lesions is reversed by intravenous administration of an NGF conjugate.

  1996cited by this paper
• Apolipoprotein E gene expression in various tissues of mouse and regulation by estrogen.

  1996cited by this paper
• Dose-response comparison of recombinant human nerve growth factor and recombinant human basic fibroblast growth factor in the fimbria fornix model of acute cholinergic degeneration.

  1995cited by this paper
• A mouse model for Down syndrome exhibits learning and behaviour deficits

  1995cited by this paper
• Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis

  1995cited by this paper
• Nerve growth factor in Alzheimer's disease: defective retrograde transport to nucleus basalis

  1995cited by this paper
• Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein.

  1994cited by this paper
• Reduced transport of [125I]nerve growth factor by cholinergic neurons and down-regulated TrkA expression in the medial septum of aged rats.

  1994cited by this paper
• Human nerve growth factor improves spatial memory in aged but not in young rats

  1994cited by this paper
• NGF level of is not decreased in the serum, brain-spinal fluid, hippocampus, or parietal cortex of individuals with Alzheimer's disease.

  1993cited by this paper
• Blood-brain barrier penetration and in vivo activity of an NGF conjugate.

  1993cited by this paper
• NGF and the treatment of Alzheimer's disease.

  1993cited by this paper
• Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a possible future treatment strategy.

  1993cited by this paper
• The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth.

  1992cited by this paper
• Vitamin E protects nerve cells from amyloid βprotein toxicity

  1992cited by this paper
• Vitamin E protects nerve cells from amyloid beta protein toxicity.

  1992cited by this paper
• Estrogen as a growth factor to central nervous cells. Estrogen treatment promotes development of acetylcholinesterase-positive basal forebrain neurons transplanted in the anterior eye chamber.

  1992cited by this paper
• Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates

  1991cited by this paper
• Normal beta-NGF content in Alzheimer's disease cerebral cortex and hippocampus.

  1991cited by this paper
• Normal β-NGF content in Alzheimer's disease cerebral cortex and hippocampus

  1991cited by this paper
• Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome.

  1990cited by this paper
• The NGFI-B gene, a transcriptionally inducible member of the steroid receptor gene superfamily: genomic structure and expression in rat brain after seizure induction

  1989cited by this paper
• Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor

  1987cited by this paper
• Nerve growth factor is a neurotrophic factor for forebrain cholinergic neurons; implications for Alzheimer's disease.

  1987cited by this paper
• Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat.

  1984cited by this paper
• NGF-mediated increase of choline acetyltransferase (ChAT) in the neonatal rat forebrain: evidence for a physiological role of NGF in the brain?

  1983cited by this paper
• Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

  1978cited by this paper
• An evaluation of psychologic effects of sex hormone administration in aged women

  1953cited by this paper
• An evaluation of psychological effects of sex hormone administration in aged women. II. Results of therapy after eighteen months.

  1952cited by this paper

• Vaginal estrogen and association with dementia: A nationwide population‐based study

  2021cites this paper
• Alzheimer's disease neuropathology is exacerbated following traumatic brain injury. Neuroprotection by co-administration of nanowired mesenchymal stem cells and cerebrolysin with monoclonal antibodies to amyloid beta peptide.

  2021cites this paper
• Estrogen Signaling in Alzheimer’s Disease: Molecular Insights and Therapeutic Targets for Alzheimer’s Dementia

  2020cites this paper
• Primary hippocampal estrogenic dysfunction induces synaptic proteins alteration and neuronal cell death after single and repeated paraquat exposure.

  2019cites this paper
• Effects of Female Sex Steroids Administration on Pathophysiologic Mechanisms in Traumatic Brain Injury

  2018cites this paper
• Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury

  2017cites this paper
• Tualang Honey Attenuates Noise Stress-Induced Memory Deficits in Aged Rats

  2016cites this paper
• Alzheimer's disease, apolipoprotein E and hormone replacement therapy.

  2016cites this paper
• Learning to remember: cognitive training-induced attenuation of age-related memory decline depends on sex and cognitive demand, and can transfer to untrained cognitive domains.

  2014cites this paper
• Optimization of Menopausal Hormone Therapies for Cognitive and Brain Aging Using a Rat Model

  2013influential citation
• Continuous estrone treatment impairs spatial memory and does not impact number of basal forebrain cholinergic neurons in the surgically menopausal middle-aged rat.

  2012cites this paper
• Tonic Premarin dose-dependently enhances memory, affects neurotrophin protein levels and alters gene expression in middle-aged rats.

  2011cites this paper
• Genetic dissection of sex differences in human brain and behaviour

  2011cites this paper
• The Effects of Age, Hormone Loss, and Estrogen Treatment on Spatial Cognition in the Rat: Parameters and Putative Mechanisms

  2011cites this paper
• Neuroscientists as Cartographers: Mapping the Crossroads of Gonadal Hormones, Memory and Age Using Animal Models

  2010cites this paper
• Steroids, learning and memory

  2009cites this paper
• Immunomodulatory function of astrocytes characterization and regulation of postanoid metabolism and cytokine synthesis

  2009cites this paper
• Working Memory for Emotional Facial Expressions: Role of Estrogen in Humans and Non-Human Primates

  2008cites this paper
• Selective Effects of Cholinergic Modulation on Task Performance during Selective Attention

  2008cites this paper
• Demenz bei Frauen und Männern: das gleiche Problem?

  2007cites this paper
• Patterns of Neurotrophin Protein Levels in Male and Female Fischer 344 Rats from Adulthood to Senescence: How Young is “Young” and How Old is “Old”?

  2007cites this paper
• Oestrogen and Progesterone Reduce Lipopolysaccharide‐Induced Expression of Tumour Necrosis Factor‐α and Interleukin‐18 in Midbrain Astrocytes

  2007cites this paper
• 21 – NGF-producing Cell Transplants for Alzheimer's Disease

  2007cites this paper
• Pitfalls And Hopes in Down Syndrome Therapeutic Approaches: In the Search for Evidence-Based Treatments

  2006cites this paper
• Efecto de dosis génica de DYRK1A (minibrain) en el proceso neurodegenerativo asociado al envejecimiento: Un estudio con ratones genéticamente modificados

  2006cites this paper
• Nerve growth factor in treatment and pathogenesis of Alzheimer's disease.

  2006cites this paper
• Commentary: “Ceramide and cholesterol: Possible connections between normal aging of the brain and Alzheimer's disease. Just hypotheses or molecular pathways to be identified?” by Claudio Costantini, Rekha M.K. Kolasani, Luigi Puglielli

  2005cites this paper
• Propentofylline attenuates tau hyperphosphorylation in Alzheimer's Swedish mutant model Tg2576.

  2005cites this paper
• Direct binding of estradiol enhances Slack (sequence like a calcium-activated potassium channel) channels' activity.

  2005cites this paper
• Recent approaches to novel anti-Alzheimer therapy.

  2004cites this paper
• Mammalian Embryo in Organ Culture in Vitro as a Basic Model for Preclinical Studies in Human Neurogenesis

  2004cites this paper
• Cholesterol and Alzheimer's disease: clinical and experimental models suggest interactions of different genetic, dietary and environmental risk factors.

  2004cites this paper
• Behavioral and neurobiological markers of Alzheimer's disease in Ts65Dn mice: effects of estrogen.

  2004cites this paper
• Dose-Response Effects of Estrogen and Tamoxifen upon Methamphetamine-Induced Behavioral Responses and Neurotoxicity of the Nigrostriatal Dopaminergic System in Female Mice

  2004cites this paper
• Progesterone counteracts estrogen-induced increases in neurotrophins in the aged female rat brain

  2004cites this paper
• Mitogen‐activated protein kinase mediates purinergic‐enhanced nerve growth factor‐induced neurite outgrowth in PC12 cells

  2004cites this paper
• Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system

  2003cites this paper
• Testosterone, but not nonaromatizable dihydrotestosterone, improves working memory and alters nerve growth factor levels in aged male rats.

  2003cites this paper
• Age-related deficits as working memory load increases: relationships with growth factors.

  2003cites this paper
• A rationale for the structure of color space.

  2002cites this paper
• Gonadal Steroids, Learning, and Memory

  2002cites this paper
• Alzheimer's disease and Down's syndrome: roles of APP, trophic factors and ACh.

  2002cites this paper
• Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies.

  2002cites this paper
• Spatial memory testing decreases hippocampal amyloid precursor protein in young, but not aged, female rats.

  2002cites this paper
• The role of hormone replacement therapy in the prevention of Alzheimer disease.

  2002cites this paper
• Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome.

  2002cites this paper
• Peripheral and dual binding site acetylcholinesterase inhibitors: implications in treatment of Alzheimer's disease.

  2001cites this paper